These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7901181

  • 1. Iron modulates neuroleptic-induced effects related to the dopaminergic system.
    Ben-Shachar D, Livne E, Spanier I, Zuk R, Youdim MB.
    Isr J Med Sci; 1993 Sep; 29(9):587-92. PubMed ID: 7901181
    [Abstract] [Full Text] [Related]

  • 2. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
    Bishnoi M, Kumar A, Chopra K, Kulkarni SK.
    Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
    [Abstract] [Full Text] [Related]

  • 3. Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptake.
    Ben-Shachar D, Livne E, Spanier I, Leenders KL, Youdim MB.
    J Neurochem; 1994 Mar; 62(3):1112-8. PubMed ID: 7906714
    [Abstract] [Full Text] [Related]

  • 4. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 5. The possible role of dopamine autoreceptors in neuroleptic atypicality.
    Javitt DC, Weinstein SL, Opler LA.
    Psychiatr Dev; 1988 Jun; 6(1):57-71. PubMed ID: 2902622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO.
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [Abstract] [Full Text] [Related]

  • 9. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    Ben-Shachar D, Pinhassi B, Youdim MB.
    Eur J Pharmacol; 1991 Sep 17; 202(2):177-83. PubMed ID: 1687031
    [Abstract] [Full Text] [Related]

  • 10. Classification of neuroleptics: implications for tardive dyskinesia.
    Christensen AV.
    Pol J Pharmacol Pharm; 1985 Sep 17; 37(3):295-309. PubMed ID: 2866499
    [Abstract] [Full Text] [Related]

  • 11. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M, Chopra K, Kulkarni SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1473-8. PubMed ID: 18554768
    [Abstract] [Full Text] [Related]

  • 12. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA, Yassa R, Llorca PM.
    Encephale; 1993 Aug 01; 19(6):657-61. PubMed ID: 12404786
    [Abstract] [Full Text] [Related]

  • 13. Brain iron homeostasis.
    Moos T.
    Dan Med Bull; 2002 Nov 01; 49(4):279-301. PubMed ID: 12553165
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb 01; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 15. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1981 Dec 01; 42(12):455-7. PubMed ID: 6118358
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
    Haleem DJ.
    J Coll Physicians Surg Pak; 2006 Aug 01; 16(8):556-62. PubMed ID: 16899192
    [Abstract] [Full Text] [Related]

  • 17. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul 01; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 18. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK, Bishnoi M, Chopra K.
    Indian J Exp Biol; 2009 Feb 01; 47(2):91-7. PubMed ID: 19374163
    [Abstract] [Full Text] [Related]

  • 19. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence.
    Gold R, Lenox RH.
    J Clin Psychiatry; 1995 Oct 01; 56(10):476-83. PubMed ID: 7559375
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
    Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI.
    J Neurosci Res; 2006 Aug 15; 84(3):675-82. PubMed ID: 16810690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.